SCHEDULE: Goldman Sachs Adjusts REPLIMUNE GROUP Stake

Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have updated their beneficial ownership filing for REPLIMUNE GROUP INC, reporting a 5.3% stake.

Summary

• This filing is a Schedule 13G, indicating a change in beneficial ownership of REPLIMUNE GROUP INC common stock.
• The reporting persons are THE GOLDMAN SACHS GROUP, INC. and GOLDMAN SACHS & CO. LLC.
• As of June 30, 2026, the aggregate amount beneficially owned by each reporting person is 4,418,837.86 shares.
• This represents 5.3% of the class of securities.
• Goldman Sachs & Co. LLC is identified as a broker-dealer and investment adviser.
• The filing confirms that these securities were acquired and are held in the ordinary course of business and not for the purpose of influencing control of the issuer.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing as neutral to slightly negative, as it primarily reports a change in beneficial ownership without new operational or financial disclosures.

Positives

• Goldman Sachs & Co. LLC, a registered broker-dealer and investment adviser, is involved, suggesting institutional interest.
• The filing explicitly states that the securities are held in the ordinary course of business, not for control purposes.

Negatives

• The filing does not provide any new operational or financial performance data for REPLIMUNE GROUP INC.
• The significant stake held by a large financial institution could imply potential future market activity or influence.

Risks

• The filing does not explicitly mention any risks related to REPLIMUNE GROUP INC's operations or market position.

Future Outlook

No specific future outlook or guidance for REPLIMUNE GROUP INC is provided in this filing, as it pertains to beneficial ownership.

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11."
• "After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct."

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for large institutional investors like Goldman Sachs, indicating their role as significant market participants. The 5.3% stake suggests a notable, but not controlling, position in REPLIMUNE GROUP INC.

Stakeholder Impact

• Shareholders: The filing may signal institutional confidence or a change in the investment landscape for REPLIMUNE GROUP INC, potentially influencing market perception.
• Management: The reporting of a significant stake by a major financial institution is a standard disclosure that management must acknowledge.

Next Steps

• The filing itself represents a completed action of reporting a change in beneficial ownership.
• Future actions would depend on Goldman Sachs's investment strategy regarding REPLIMUNE GROUP INC.

Key Dates

Keywords

Schedule 13G, Beneficial Ownership, Goldman Sachs, REPLIMUNE GROUP INC, Common Stock, Investment Adviser, Broker-Dealer